Roland Berger
This is some text inside of a div block.
Roland Berger
Multiple Chart
Healthcare & Pharmaceuticals
Regulatory and Compliance
Two-section layout: left side features a large quote and key stats; right side includes two infographics—bar graph and circular breakdown—on AMR R&D activities; uses magenta and gray tones; clean visual hierarchy.
Highlights the grave risks of antimicrobial resistance (AMR), including high death tolls and economic losses if left unaddressed. Emphasizes the growing momentum in R&D, with 138 projects in development. Showcases the breakdown of antifungal, antibacterial, and vaccine initiatives and promotes a sense of urgency around AMR-related healthcare investment and innovation.
AMR, antibiotics, R&D, resistance, global health, WHO, economic loss, vaccines, antibacterial, antifungal
date
The consequences of not addressing the problem of AMR would be tremendous But the fight against AMR is gaining momentum